Pfizer Launches a New Social Media Channel.....on SlideShare.

While Pfizer has rapidly elevated its standing in life sciences social media circles, the announcement today that it is creating a “social media channel” on SlideShare suggests that the company may be over thinking its social media strategy. I have nothing against SlideShare (I even have some of my own presentations on the site) but SlideShare isn’t exactly a “household name” in social media circles. And, IMHO it isn’t exactly the most flexible or interactive social media platform available today. 

Ray Kerins Pfizer’s Vice President for External Affairs and Worldwide Communication proclaimed in as statement prepared for the channel’s launch: 

"This channel offers an integrated social media experience, delivering a variety of content -- presentations, video, blog posts -- via the largest online resource for sharing presentations.”We’re pleased to be the first company in a regulated industry to create a custom channel on SlideShare." 

Its launch was announced today at the 6th Annual PR & Communications ExL Pharma Summit being held this week at Pfizer’s New York world headquarters. After learning about the launch I visited the “channel” to have a peek.

Expecting a treasure drove of Pfizer blog posts, videos and other content I was sadly disappointed to find only a handful of PowerPoint presentations about Pfizer’s finances and quarterly results at the site (there were no blog posts, no videos, no followers and no tweets as promised). Also, it appears that the comments and wall section are currently disabled (I logged into my SlideShare account and was still unable to comment on the Pfizer site although @skypen managed to post a comment there). Although Pfizer may think it is leading the pharmaceutical social media vanguard, the launch of its SlideShare channel has already violated one of the basic tenets of social media— no over promising. And, for now, it appears that the Pfizer channel has been set up as a broadcast medium rather than an interactive one—another big no-no in social media circles. 

Maybe I expected too much of Pfizer (after hearing Ray talk at several social media conferences) and I am being too critical. But, launching a social media channel devoid of content and interactive feature is no longer de rigueur on the social web.  If this is what the world’s largest, and possibly one of the most social-media savvy, pharmaceutical companies has to offer, then we may be in for a long and bumpy social media ride in the life sciences industry!!!! 

Until next time... 

Good Luck and Good Viewing!!!!!!!

 

Calling All Podcasters and PowerPoint Aficionados

We recently added a feature to BioCrowd called BioCrunch. Our goal for BioCrunch is to provide Bcrowd members with relevant, interesting and “fresh” content. Vincent and I are big fans of podcasts and PowerPoint presentations! That said, please contact me  if you are interested in contributing content for BioCrowd’s BioCrunch feature.

Until next time…

Good Luck and Good Surfing!!!!